scholarly journals Development and pilot test of a new set of good practice indicators for chronic cancer pain management

2014 ◽  
Vol 19 (1) ◽  
pp. 28-38 ◽  
Author(s):  
P.J. Saturno ◽  
I. Martinez-Nicolas ◽  
I.S. Robles-Garcia ◽  
F. López-Soriano ◽  
D. Angel-García
Keyword(s):  
Pain Management ◽  
Cancer Pain ◽  
Good Practice ◽  
Pilot Test ◽  
Cancer Pain Management ◽  
Chronic Cancer Pain

Chronic cancer pain management with the Du Pen epidural catheter

1990 ◽  
Vol 13 (3) ◽  
pp. 176-182 ◽  
Author(s):  
Anna R. Williams ◽  
Kelli E. Beaulaurier ◽  
Debbie L. Seal
Keyword(s):  
Pain Management ◽  
Cancer Pain ◽  
Epidural Catheter ◽  
Cancer Pain Management ◽  
Chronic Cancer Pain

Implementing practice change in chronic cancer pain management: clinician response to a phase III study of ketamine

2014 ◽  
Vol 44 (6) ◽  
pp. 586-591 ◽  
Author(s):  
J. R. Hardy ◽  
O. Spruyt ◽  
S. J. Quinn ◽  
L. R. Devilee ◽  
D. C. Currow
Keyword(s):  
Pain Management ◽  
Cancer Pain ◽  
Practice Change ◽  
Phase Iii ◽  
Cancer Pain Management ◽  
Chronic Cancer Pain ◽  
Phase Iii Study

Revision and Validation of a Medication Assessment Tool for Chronic Cancer Pain Management

2012 ◽  
Vol 29 (8) ◽  
pp. 640-646 ◽  
Author(s):  
Sewar S. Salmany ◽  
Sara M. Koopmans ◽  
Imad M. Treish ◽  
Rana El Jaber ◽  
Shorouq Telfah ◽  
...  
Keyword(s):  
Pain Management ◽  
Cancer Pain ◽  
Assessment Tool ◽  
Cancer Pain Management ◽  
Chronic Cancer Pain

Long- and short-acting opioids in cancer pain management: What is the best ratio?

2014 ◽  
Vol 32 (31_suppl) ◽  
pp. 206-206
Author(s):  
Alison Wiesenthal ◽  
Natalie Moryl ◽  
Paul A. Glare
Keyword(s):  
Pain Management ◽  
Cancer Pain ◽  
Breakthrough Pain ◽  
Retrospective Chart Review ◽  
Clinic Visit ◽  
Comprehensive Cancer Center ◽  
Cancer Center ◽  
Cancer Pain Management ◽  
Short Acting ◽  
Chronic Cancer Pain

206 Background: Many cancer patients experience chronic and breakthrough pain necessitating the use of both immediate release (IR) and extended release (ER) opioids. The common strategy in treating chronic cancer pain is using ER opioids with the addition of IR opioids for breakthrough pain. The National Comprehensive Cancer Network recommends IR dosing at 0.1-0.2 times the daily ER dose as needed every 1 hour for breakthrough pain, though data is lacking to validate this recommendation. The aim of this exploratory study was to review the current practice in prescribing IR and ER opioids and the IR/ER ratio used in cancer pain management at one comprehensive cancer center (CCC). Methods: We performed a retrospective chart review of 54 consecutive patients at a CCC over a 6 month period. IR/ER doses, dose adjustments and satisfaction with analgesia were recorded. Adjustments in treatment plans were made based on patients' report of effectiveness and side effects associated with ER and IR opioids. Results: 19 of 54 (35%) patients reported adequate analgesia, with the average daily prescribed IR/ER ratio of 0.6 (range 0 to 3.75). In this group, IR opioids were unchanged during the clinic visit. The ER opioids, on average, were also unchanged, though decreased by 25% and increased by 50% in a few cases over serial clinic visits. Of those patients reporting suboptimal analgesia during the clinic visit (65%), 80% had their ER opioids increased, 6% had IR opioids increased, and 9% had both IR and ER increased. The ER opioids were increased by 40% on average and IR by 11% with the average IR/ER ratio changing from 0.5 (range 0-2) to 0.37 (range 0-1.13). Conclusions: These preliminary data highlight the great variability between patient preferences and clinician decisions in terms of IR/ER opioid ratios. In this retrospective study, analgesia was better in the group using higher IR doses with a higher IR/ER ratio. At the same time, patients with suboptimal analgesia had their ER opioids titrated faster and higher than the IR opioids. More studies are needed to determine best practice in the prescribing of long and short acting opioids for management of chronic cancer pain.

scholarly journals Chronic cancer pain management by the nursing team

Revista Dor ◽  
2016 ◽  
Vol 17 ◽  
Author(s):  
Anara da Luz Oliveira ◽  
Natália da Palma Sobrinho ◽  
Beatriz Aparecida Silva Cunha
Keyword(s):  
Pain Management ◽  
Cancer Pain ◽  
Cancer Pain Management ◽  
Chronic Cancer Pain ◽  
Nursing Team

Cancer pain management

2014 ◽  
Vol 155 (3) ◽  
pp. 93-99
Author(s):  
Péter Heigl
Keyword(s):  
Quality Of Life ◽  
Pain Management ◽  
Pain Relief ◽  
Life Expectancy ◽  
Cancer Pain ◽  
Cancer Pain Management ◽  
Medical Activity ◽  
Short Summary ◽  
Adequate Quality

Pain is a significant and alarming symptom of cancer seriously affecting the activity and quality of life of patients. Recent research proved that inadequate analgesia shortens life expectancy. Therefore, pain relief is not only a possibility but a professional, ethical and moral commitment to relieve patients from suffering, as well as ensure their adequate quality of life and human dignity. Proper pain relief can be achieved with medical therapy in most of the cases and the pharmacological alternatives are available in Hungary. Yet medical activity regarding pain relief is far from the desired. This paper gives a short summary of the guidelines on medical pain management focusing particularly on the use of opioids. Orv. Hetil., 2014, 155(3), 93–99.

Sign in / Sign up

Export Citation Format

Share Document